Information:
Error:
ID
34413
Description
Role of Vitamin D in Reducing the Relapse Rate in Patients With Multiple Sclerosis; ODM derived from: https://clinicaltrials.gov/show/NCT01753375
Link
https://clinicaltrials.gov/show/NCT01753375
Keywords
Versions (1)
- 1/17/19 1/17/19 -
Copyright Holder
GSK group of companies
Uploaded on
January 17, 2019
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Multiple Sclerosis NCT01753375
Eligibility Multiple Sclerosis NCT01753375
- StudyEvent: Eligibility
Similar models
Eligibility Multiple Sclerosis NCT01753375
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
ID.1
Item
age between 18-55 years
boolean
ID.2
Item
confirmed multiple sclerosis diagnosis according to mcdonald criteria
boolean
ID.3
Item
stable neurological functioning for at least one month prior to study entry
boolean
ID.4
Item
expanded disability scale score (edss) less than <_4.0
boolean
ID.5
Item
must have had one clinical attack in past two years and at least one new silent t2 or gadolinium-enhancing lesion on mri within the past one year.
boolean
ID.6
Item
willing to participate for the entire 52-week period
boolean
ID.7
Item
pregnant or nursing.
boolean
ID.8
Item
connective tissue disease (sle, sjogren's disease)
boolean
ID.9
Item
endocrine disease (hyperthyroidism, hyperparathyroidism)
boolean
ID.10
Item
any medical condition predisposing to hypercalcaemia, nephrolithiasis or renal insufficiency
boolean